Here is a statistic worth sitting with: more than half of midlife women experience vaginal dryness, irritation, or pain with sex as estrogen declines. And the great majority of them never receive treatment for it. Not because treatment doesn't exist. It exists, it's effective, and some of it is available without a prescription. They don't receive treatment because nobody talks about this symptom: not their clinicians, who rarely ask, and not the women themselves, who often assume it's just part of getting older, or feel it's too private to raise.

So let's talk about it plainly.

If you've noticed dryness, burning, itching, a feeling of tightness, discomfort during sex that wasn't there before, or even an uptick in urinary urgency or UTIs, you are experiencing one of the most well-documented effects of perimenopause. It has a medical name, a clear mechanism, and a menu of treatments with strong evidence behind them.

What's Actually Happening

The tissue of the vagina and vulva is dense with estrogen receptors. Estrogen is what keeps that tissue thick, elastic, well-supplied with blood, and naturally lubricated. It also maintains the slightly acidic environment that supports a healthy vaginal microbiome.

As estrogen declines through perimenopause, that support system winds down:

  • The tissue thins. The vaginal walls become thinner and less elastic, which can create sensations of tightness, friction, or fragility.
  • Lubrication decreases. Both baseline moisture and the lubrication response during arousal diminish, because reduced blood flow means less of the fluid that normally transudates through the vaginal walls.
  • The pH rises. The vaginal environment becomes less acidic, which shifts the microbiome and contributes to irritation and more frequent infections.
  • The urinary tract is affected too. The urethra and bladder share the same estrogen-dependent tissue, which is why urinary urgency, discomfort, and recurrent UTIs often arrive alongside the vaginal symptoms.

None of this is about hygiene, attraction, or anything you did or didn't do. It is a predictable tissue response to a changing hormone level, as described by the Cleveland Clinic.

It Has a Name: GSM

In 2014, the major menopause and sexual-health societies replaced the older term "vaginal atrophy" with genitourinary syndrome of menopause (GSM). The change mattered for two reasons. First, "atrophy" is a demoralizing word to attach to anyone's body. Second, the old term understated the condition: GSM covers the full collection of vaginal and urinary symptoms driven by estrogen loss, including dryness, burning, itching, pain with sex (dyspareunia), urinary urgency, and recurrent UTIs.

You don't need every symptom on that list for it to be GSM. Many women start with one: usually dryness or new discomfort during sex.

The Part Nobody Tells You: It's Progressive

Most perimenopause symptoms are a storm that passes. Hot flashes peak and fade. Sleep often recovers. Mood typically restabilizes after menopause as hormones stop swinging.

GSM is different. Because it's caused by the absence of estrogen rather than the fluctuation of it, the tissue changes continue and typically worsen over time without treatment. Waiting it out is the one strategy that reliably fails.

That sounds discouraging, but it carries the most encouraging fact in this entire article: GSM is among the most treatable conditions in menopausal medicine, and treatment works whenever you start. You have not missed a window. There is no point of no return.

What Helps, From Simplest to Strongest

Vaginal moisturizers (over the counter)

Moisturizers are the first-line starting point and are often confused with lubricants. The difference matters. A moisturizer is used regularly, typically two to three times per week regardless of sexual activity, to improve the baseline hydration of the tissue. Think of it as skincare for vaginal tissue. Hyaluronic-acid-based products have reasonable evidence and are widely available.

Used consistently, moisturizers meaningfully reduce day-to-day dryness and irritation for many women with mild symptoms. What they don't do is reverse the underlying tissue changes.

Lubricants (for the moment, not the baseline)

A lubricant is used during sex to reduce friction. Water-based and silicone-based options each have trade-offs: silicone lasts longer and works well for significant dryness, while water-based products are lighter and compatible with everything. Avoid warming, tingling, or fragranced products, which irritate exactly the tissue you're trying to protect. If you're using condoms, skip oil-based lubricants, which degrade latex.

Low-dose vaginal estrogen (the gold standard)

For moderate to severe GSM, low-dose vaginal estrogen is the most effective treatment available, full stop. It comes as a cream, tablet, insert, or ring, and it works where the problem is: locally, on the tissue itself, restoring thickness, elasticity, lubrication, and a healthy pH. Because the dose is low and acts locally, very little is absorbed into the rest of the body.

Two facts are worth knowing here. First, the evidence for vaginal estrogen is decades deep, and major medical organizations including ACOG and The Menopause Society consider it safe and effective for most women, including many who can't or don't want to use systemic hormone therapy. Second, in November 2025 the FDA removed the boxed safety warning from low-dose vaginal estrogen entirely, formally acknowledging what the evidence had shown for years: the old warnings, inherited from studies of much higher-dose systemic hormones, dramatically overstated the risk of these local treatments. An entire generation of women avoided the most effective treatment for GSM because of a warning label that no longer exists.

Other prescription options

Vaginal DHEA (prasterone) is a nightly insert that the tissue converts into local estrogens and androgens; it has good evidence for painful sex. Ospemifene is an oral medication that acts selectively on vaginal tissue, an option when inserts aren't preferred. And for women whose GSM arrives alongside hot flashes, sleep disruption, and other symptoms, systemic hormone therapy can address the whole picture at once, though many women still add low-dose vaginal estrogen for complete relief of local symptoms.

What to skip

Douching makes the pH problem worse. "Tightening" gels and wands are marketing, not medicine. Fragranced washes irritate thinning tissue. And the supplement aisle has no product with credible evidence for reversing GSM, whatever the label promises.

About Sex, Pain, and the Avoidance Loop

When sex starts to hurt, a predictable cycle often follows: pain leads to anticipating pain, anticipation kills arousal, reduced arousal means less natural lubrication, and the next attempt hurts more. Many couples quietly stop trying, and many women conclude that their desire has simply died, when what actually happened is that their body learned to brace.

This loop is worth naming because it's breakable, and treating the tissue is how the cycle unwinds: when sex stops hurting, anticipation eases, arousal returns, and desire often follows. If your interest in sex has faded alongside the dryness, the two are likely connected, and we've written about what happens to libido in perimenopause in its own right.

One more practical note: regular sexual activity (with a partner or solo), once comfort is restored, genuinely helps maintain tissue health by promoting blood flow. It is the rare medical recommendation that is also good news.

The Bottom Line

Vaginal dryness in perimenopause is common, physical, progressive, and exceptionally treatable. The silence around it is the only part of this condition with no good reason to exist.

Start with a moisturizer and a good lubricant; for many women with mild symptoms, that's enough. If symptoms are moderate, severe, or progressing, the gold-standard treatment is a prescription away, and the evidence behind it has never been clearer or its safety label cleaner.

Getting that prescription requires a clinician who takes GSM seriously, asks about it, and knows the current evidence. That's exactly the kind of care we're building: online visits with clinicians trained specifically in perimenopause, opening in late 2026. You can get first access here. And if you're still mapping what's happening to your body, our free 3-minute assessment will show you how this symptom fits your bigger pattern.